Index of Articles From 1996 TAGlines

Now Live: Breaking Research From AIDS 2008: Podcasts, Interviews, Videos & More >>

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Index of Articles From 1996 TAGlines

About TAGlines

December, 1996

November, 1996
- CPCRA v. Syntex:
  Effect of ddI on Ganciclovir May Explain Disparity Between Two Prophylaxis Studies
- Clues to Non-Progressors:
  Flurry of Discoveries in Multiple Labs Leads to Identification of HIV's Second Receptor -- And New Therapeutic Target
- TAG Debuts Its Wasting Report
October, 1996
- Recipes for Failure:
  'Early' Is Right, They Say, Unless of Course Your Regimen's Wrong; Then You're Shit Out of Luck
- Caution, Flammable:
  Smoldering Embers of HIV's 'Raging Fire,' Partly Doused, Threaten to Rekindle the Blaze
- Hitting it Early, Hard: The Aftermath
August/September, 1996
- Viral Load Comes of Age
  Propelled by Results from Multiple Studies, Viral Load Monitoring Lunges to the Forefront of HIV Medicine
- Aaron Diamond's Dynamic Duo: The Latest Word on Protease Resistance
  Treatment Activists Sit Down with Vancouver High Fliers, Try to Make Sense Out of the New Cries of 'Eureka' Creating hysteria with the 'e' word
- Resisitance Rules - Revised
  Amino acid substitutions conferring reduced sensitivity to selected protease inhibitors
July, 1996
- Threshold, Schmeshold
  Long-Awaited Research Paper Takes on the Viral Diversity Threshold, Cannibalistic CTLs and NSI-to-SI Switch - Shining star of the new guard
- Sacked on the Hill
  Licking Their Wounds Following a FY 1996 Budgetary Revocation, Activists Regroup for the Battle of 1997 - Of friends and fair weather
- Random Gleanings
  Can HIV Be Eradicated from an Infected Individual?; The Seventy Percent Solution (a/k/a "Fools Rush In ..."); Nearly One Third Either Slow or Fast Progressors
June, 1996
- Clinically Clueless
  Keystone Group Addresses Crisis in Post-Marketing Treatment Research and Access to FDA-Approved Therapies - So many drugs, so little data
- Review and Reform
  OAR Advisory Panel Would Meld 12 Trials Networks into One and Requests Improved Institute Collaboration - 15 studies of oral interferon
- The Six Area Review Panels (ARPs)
  Of the NIH AIDS Research Program Evaluation Working Group of the Office of AIDS Research (OAR) Advisory Council (the "Levine Committee")
- A Word About TAG
May, 1996
- Monitoring, Not Management
  Roche Requests Approval from FDA's Blood Products Committee for Its PCR Diagnostic - 7/10ths a log of 'noise'
- Deconstructing the Drama
  Former ACT UP/NY Scientific Wunderkind Denounces Movement As "Messianic Utopianism" - AIDS activism as religious cult
- Comparing Protease Combinations
  Reported maximum average reductions in plasma RNA with selected protease inhibitor combinations (in treament naive/experienced* individuals)
- Random Gleanings
  A Tale of Two Epidemics; Researchers Report
April, 1996
- The Race to Ritonavir
  FDA Approves Second Protease Inhibitor in Record Time - As Abbott Chief Warns Many to "Wait for the data" - And indinavir makes three
- Medications contraindicated with the use of ritonavir
- Comparing the (RTI) Combinations
  Reported maximum average reductions in plasma HIV RNA with selected RTI combination regimens (in treatment naive individuals)
- Azithro v. Clarithro
  Two Drugs Might Be Better Than One for Prophylaxis of M. Avium Disease, But Are Any of Them Clarithromycin? - 24-29% with resistant bugs
- Random Gleanings
  Expanded Access for Nevirapine and Delavirdine; OAR Loses Out on 1996 Budgetary Authority; Lowering the Vaccine Goalpost
- Would You Like To Continue Receiving TAGline?
March, 1996
- White House Summit
  Clinton, Shalala, Fleming Host Gathering of AIDS Advocates, Care Givers and People Living with HIV at Day-Long Conference - Election year sleight of hand?
- Resistance Rules
  Amino acid substitutions conferring reduced sensitivity to selected protease inhibitors
- Retroviral Reprise
  Confab's Clarion Call: "Get It Down and Keep It Down," with Hints - And Only Hints - Of How To Get There - Heyday for RNA
- Random Gleanings
  Message from CPCRA 007 and other combination studies; AZT resistant virus more virulent than wild-type?
- Would You Like To Continue Receiving TAGline?
February, 1996
- Hasta la vista, ACTG!
  ACTG Oncology Committee Finds New Home at National Cancer Institute, But Funding Is Woefully Inadequate - Six studies slated
- Mother Pataki's Cupboard
  AIDS Therapeutics Omitted from the NY State ADAP Formulary as of 1/96
- Shakedown
  Federal Budget Shutdown and Flood of New Approvals Combine to Threaten Access to FDA-Approved AIDS Drugs - Bankrupt ADAPs
- Notice to our readers
  "...February issue of TAGline is the first for calendar 1996..."
- Would You Like To Continue Receiving TAGline?
- A Word About TAG

Back to the Treatment Action Group index page

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.